[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100524333":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":35,"locations":44,"responsibleParty":62,"collaborators":26,"id":65,"slug":66,"hasResults":67,"nctId":68,"briefTitle":69,"officialTitle":69,"acronym":26,"eligibilityCriteria":70,"healthyVolunteers":67,"sex":71,"minAge":72,"maxAge":26,"enrollmentInfo":73,"targetDuration":26,"studyType":76,"phases":77,"briefSummary":79,"conditions":80,"keywords":83,"overallStatus":47,"whyStopped":26,"lastUpdateSubmitDate":90,"lastUpdatePostDateStruct":91,"startDateStruct":94,"completionDateStruct":96,"leadSponsor":98,"locationsCount":99},{"fullName":5,"class":6},"Corewell Health East","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Arm 1 (6.35cm 20 gauge ultralong intravenous catheter)","ACTIVE_COMPARATOR","Arm 1 Device: B. Braun 6.35cm 20 gauge ultralong intravenous catheter",[13],"Device: B. Braun 6.35cm 20 gauge ultralong intravenous catheter",{"label":15,"type":16,"description":17,"interventionNames":18},"Arm 2 (5.71 cm 20 gauge Accucath)","EXPERIMENTAL","Arm 2 Device: BD 5.71 cm 20 gauge Accucath, ultralong intravenous catheter with guide wire",[19],"Device: BD 5.71 cm 20 gauge Accucath",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DEVICE","B. Braun 6.35cm 20 gauge ultralong intravenous catheter","B Braun Medical Inc, 6.35cm 20 gauge ultralong intravenous catheter",[9],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"BD 5.71 cm 20 gauge Accucath","Bard Access Systems, Inc, BD 5.71 cm 20 gauge ultralong intravenous catheter with guide wire",[15],[32],{"name":33,"affiliation":5,"role":34},"Amit Bahl, MD","PRINCIPAL_INVESTIGATOR",[36,40],{"name":33,"role":37,"phone":38,"phoneExt":26,"email":39},"CONTACT","248-898-9111","amit.bahl@corewellhealth.org",{"name":41,"role":37,"phone":42,"phoneExt":26,"email":43},"Maureen Cooney, RN","248-551-0099","maureen.cooney@corewellhealth.org",[45],{"facility":46,"status":47,"city":48,"state":49,"zip":50,"country":51,"countryCode":52,"cosmosGeoPoint":53,"geoPoint":58,"contacts":59},"Beaumont Hospital - Royal Oak","RECRUITING","Royal Oak","Michigan","48073","United States","US",{"type":54,"coordinates":55},"Point",[56,57],-83.14465,42.48948,{"lat":57,"lon":56},[60],{"name":33,"role":37,"phone":61,"phoneExt":26,"email":39},"2488989111",{"type":34,"investigatorFullName":63,"investigatorTitle":64,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"Amit Bahl","Director Emergency Medicine Ultrasound","100524333","evaluating-the-role-of-the-guidewire-in-peripheral-intravenous-access-a-randomized-controlled-trial-of-ultrasound-guided-catheter-survival-100524333",false,"NCT06107361","Evaluating the Role of the Guidewire in Peripheral Intravenous Access: A Randomized Controlled Trial of Ultrasound-Guided Catheter Survival","Study Participants Inclusion Criteria:\n\n≥ than 18 years old Vascular Access Score of 4 or 5\n\nVascular Access Score:\n\n1. Visible with distention and easily palpable\n2. Visible and easily palpable\n3. Not visible and easily palpable\n4. Visible and poorly palpable\n5. Not visible and poorly or non-palpable\n\nStudy participants exclusion criteria:\n\n\\\u003C18 years old Restricted mobility of elbow joint Cognitively impaired. Skin complications that limit access to the potential IV site\n\nClinician Participants Inclusion Criteria:\n\nClinician working in the emergency department at Corewell Health William Beaumont University Hospital (physician, advanced practice provider, nurse, technician) Competency in Operation STICK, which is an vascular access training program.\n\nClinician participants exclusion criteria:\n\nNone","ALL","18 Years",{"count":74,"type":75},360,"ESTIMATED","INTERVENTIONAL",[78],"NA","This is a prospective, parallel, non-blinded, two-arm randomized controlled trial of intravenous catheter failure evaluating the impact of a built-in guide wire. The objective of this study is to demonstrate that the control ultralong intravenous catheter (IV) without the guide wire is non-inferior to the experimental catheter with the guide wire. After obtaining consent, eligible patients will be randomly allocated to control Arm 1 (ultralong intravenous catheter) or experimental Arm 2 (ultralong intravenous catheter with guide wire) in a ratio of 1:1 via a computer-generated randomization schedule. The participants will be followed to collect data until the catheter is removed.",[81,82],"Peripheral Intravenous Vein Catheter Phlebitis","Intravenous Infection",[84,85,86,87,88,89],"PIV","BBraun Ultra Long Catheter","BD Accucath","Phlebitis","IV infection","peripheral intravenous","2026-06-09",{"date":92,"type":93},"2026-06-10","ACTUAL",{"date":95,"type":93},"2023-11-07",{"date":97,"type":75},"2026-07-31",{"name":5,"class":6},1]